MAPT and Alzheimer disease: The MAPT P301L mutation was originally found in familial frontotemporal dementia patients and is used to generate a mouse model of tauopathy characterized by the aggregation of hyperphosphorylated tau protein, which is a common pathology of AD and frontotemporal dementia.